TransCode Therapeutics, Inc.’s Post

TransCode Therapeutics, Inc. reposted this

View organization page for RNA Leaders, graphic

5,760 followers

New speaker Announcement! We're excited to announce the latest speakers to join RNA Leaders Europe to help accelerate the innovation and commercialization of RNA therapeutics and vaccines! Zdravka Medarova - Founder & CTO, TransCode Therapeutics, Inc. 🌐 Presenting: Translating Targeting Metastatic Cancer with Oligos Jacqueline Fok - Investment VP, Softbank Vision Fund 🎤 Keynote Panel: Investing in RNA Medicines and Technologies Tomaž Einfalt - Principle Investigator II / Project Team Lead xRNA, Novartis 🔄 Round Table Host: mRNA stability during delivery Covadonga Paneda - COO, Altamira Therapeutics 💡 Presenting: Targeting Inflamed or Cancerous Tissues via Novel Peptide Delivery Sujin Lee - Professor, Emory University 📊 Presenting: Developing a mRNA Respiratory Vaccine Phil Challis - VP Product Development, etherna 🗣️ Leading Discussion: Building Quality Processes in RNA Therapeutics 📆 Save the Date: 13-14 March 2024 📍 Congress Center Basel, Basel, Switzerland Don't miss the chance to network with those shaping the future of RNA. Review the full agenda at: https://lnkd.in/dzfJxf-z #RNALeaders #RNA #Oligos #mRNA

  • New Speakers join RNA Leaders Europe including Transcode Therapeutics, Softbank Vision Fund, Novartis, Altamira, Emory University & eTheRNA
Erik Manting

CEO Mendus AB (publ)

7mo

Great to see Transcode founder and CSO Zdravka Medarova contribute as speaker at the RNA Leaders congress.

To view or add a comment, sign in

Explore topics